European Union - English - EMA (European Medicines Agency)

cis bio international - yttrium (90y) chloride - radionuclide imaging - diagnostic radiopharmaceuticals - to be used only for the radiolabelling of carrier molecules which have been specifically developed and authorised for radiolabelling with this radionuclide.radiopharmaceutical precursor - not intended for direct application to patients.

Israel - English - Ministry of Health

isotopia molecular imaging, israel - yttrium (90y) chloride - solution for injection - yttrium (90y) chloride 1850 mbq - yttrium (90-y) compounds - ytracis is indicated to be used only for the radiolabelling of carrier molecules which have been specifically developed and authorized for radiolabelling with this radionuclide. radiopharmaceutical precursor - not intended for direct application to patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - yttrium(90y) chloride -

Singapore - English - HSA (Health Sciences Authority)

qt instruments (s) pte ltd - yttrium (90) chloride - solution - 1850 mbq at calibration time and date - yttrium (90) chloride 1850 mbq at calibration time and date

European Union - English - EMA (European Medicines Agency)

sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - immune sera and immunoglobulins, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5.1).obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.1).

United States - English - NLM (National Library of Medicine)

emergent biodefense operations lansing, llc - bacillus anthracis strain v770-np1-r antigens (unii: 873oi62848) (bacillus anthracis strain v770-np1-r antigens - unii:873oi62848) - bacillus anthracis strain v770-np1-r antigens 100 ug in 1 ml - biothrax is a vaccine indicated for the active immunization for the prevention of disease caused by bacillus anthracis in persons 18 through 65 years of age. the efficacy of biothrax for post-exposure prophylaxis is based solely on studies in animal models of inhalational anthrax. do not administer biothrax to individuals with a history of anaphylactic or anaphylactic-like reaction following a previous dose of biothrax or any component of the vaccine, including aluminum, benzethonium chloride, and formaldehyde. [see description (11).] pregnancy category d. [see warnings and precautions (5.3)] healthcare practitioners are encouraged to register women who receive biothrax during pregnancy in emergent’s vaccination pregnancy registry by calling 1-619-553-9255. male fertility: a retrospective study was performed at an in-vitro fertilization clinic to evaluate whether biothrax may impact reproductive function in men. this study compared semen parameters, embryo quality, and pregnancy outcomes in 254 male cli

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

kck pharmaceutical industries sdn. bhd. - calcium carbonate; sodium bicarbonate; magnesium carbonate,light; simethicone -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - bacillus anthracis (sterne 34f2 strain) - parenteral liquid/solution/suspension - bacillus anthracis (sterne 34f2 strain) vaccine-microbial active 0.0 ml - immunotherapy - cattle | pigs | sheep | beef | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | ew - bacillus anthracis | anthrax

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

y.s.p. industries (m) sdn bhd - tramadol hydrochloride -